AGT, angiotensinogen, 183

N. diseases: 765; N. variants: 43
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0085580
Disease: Essential Hypertension
Essential Hypertension
0.600 GeneticVariation disease BEFREE High risk for essential hypertension in males conferred by g.15241A>G polymorphism in intron 3 of AGT gene. 22799745 2013
CUI: C0085580
Disease: Essential Hypertension
Essential Hypertension
0.600 GeneticVariation disease BEFREE Hypertensive patients carrying the control genotype of rs2074192 (CC, OR = 2.37, 95% CI: 1.28-4.39) were associated with CAS ≥50%, while those carrying a high-EH-risk genotype of rs4240157 (OR = 2.62, 95% CI: 1.24-5.54), rs4646155 (OR = 2.44, 95% CI: 1.16-5.10), or rs4830542 (CC+CT, OR = 2.20, 95% CI: 1.03-4.69) were associated with atrial fibrillation (AF), larger left atrial diameter, and higher levels of renin-angiotensin-aldosterone system (RAAS) activation (renin and angiotensin I/II). 30542083 2019
CUI: C0085580
Disease: Essential Hypertension
Essential Hypertension
0.600 GeneticVariation disease BEFREE Patients with mild-to-moderate essential hypertension in the HOMED-BP trial were randomly allocated to first-line treatment with a calcium channel blocker (CCB), angiotensin-converting enzyme inhibitor (ACEI) or angiotensin II receptor blocker (ARB). 24192120 2013
CUI: C0085580
Disease: Essential Hypertension
Essential Hypertension
0.600 GeneticVariation disease BEFREE These results suggest that the contribution of variation in the angiotensinogen gene to the occurrence of essential hypertension is less than initially suspected, or may not be constant across populations. 7649545 1995
CUI: C0085580
Disease: Essential Hypertension
Essential Hypertension
0.600 GeneticVariation disease BEFREE T+31C polymorphism of angiotensinogen gene and essential hypertension. 11230286 2001
CUI: C0085580
Disease: Essential Hypertension
Essential Hypertension
0.600 GeneticVariation disease BEFREE Many persons with essential hypertension carry a common "susceptibility gene" at the angiotensinogen locus (chromosome 1q4) identified using linkage studies in siblings, association studies, and in studies of preeclampsia and hypertension in pregnant women. 7988084 1994
CUI: C0085580
Disease: Essential Hypertension
Essential Hypertension
0.600 GeneticVariation disease BEFREE In addition, the T235M polymorphism in the AGT product is associated with an increased risk of essential hypertension in multiple populations, making AGT a good example of a quantitative-trait locus underlying susceptibility to a common disease. 11731937 2002
CUI: C0085580
Disease: Essential Hypertension
Essential Hypertension
0.600 GeneticVariation disease BEFREE We attempted to evaluate the risk of -217G>A, -152G>A, -20A>C, -6G>A, T174M, M235T and 15241A>G polymorphisms at AGT locus along with the analyses of haplotype and epistatic interactions in causing susceptibility to EHT. 22570327 2012
CUI: C0085580
Disease: Essential Hypertension
Essential Hypertension
0.600 GeneticVariation disease BEFREE We determined the association of angiotensinogen (M235T) gene polymorphism with essential hypertension and the relationship between polymorphism in the angiotensinogen (M235T) gene and blood pressure response to ACE inhibitor (Enalapril) in patients with essential hypertension from northern Indian subjects. 22974788 2012
CUI: C0085580
Disease: Essential Hypertension
Essential Hypertension
0.600 GeneticVariation disease BEFREE Angiotensinogen gene M235T and T174M polymorphisms in essential hypertension: relation with target organ damage. 9607382 1998
CUI: C0085580
Disease: Essential Hypertension
Essential Hypertension
0.600 GeneticVariation disease BEFREE Thus, our findings suggest that in white families with type 2 diabetes, there is no linkage between the degree of albumin excretion and ACE and AGN polymorphisms, whereas the latter is related to arterial hypertension, as previously found in patients without diabetes but with essential hypertension. 10585308 1999
CUI: C0085580
Disease: Essential Hypertension
Essential Hypertension
0.600 GeneticVariation disease BEFREE We performed a meta-analysis with the aim of assessing the association of the angiotensin II type 1 (AT(1)) receptor gene A1166C polymorphism with essential hypertension in Chinese case-control studies. 20223791 2010
CUI: C0085580
Disease: Essential Hypertension
Essential Hypertension
0.600 GeneticVariation disease BEFREE Association between the angiotensinogen 235T-variant and essential hypertension in whites: a systematic review and methodological appraisal. 9403549 1997
CUI: C0085580
Disease: Essential Hypertension
Essential Hypertension
0.600 GeneticVariation disease BEFREE Renin angiotensinogen system gene polymorphisms and essential hypertension among people of West African descent: a systematic review. 26607294 2016
CUI: C0085580
Disease: Essential Hypertension
Essential Hypertension
0.600 GeneticVariation disease BEFREE The issues confronting the genetic analysis of EH are discussed by drawing from our ongoing work along the hypothesis that molecular variants of the angiotensinogen gene may constitute inherited predispositions to the condition. 11037339 2001
CUI: C0085580
Disease: Essential Hypertension
Essential Hypertension
0.600 GeneticVariation disease BEFREE The hypothesis that genetic variation at the angiotensinogen locus impacts on individual susceptibility to develop essential hypertension has motivated a substantial body of research by us and many others. 17242300 2007
CUI: C0085580
Disease: Essential Hypertension
Essential Hypertension
0.600 GeneticVariation disease BEFREE In this study, we examined the role of AGT promoter polymorphisms, including G-217A, A-6G and M235T variants, and their promoter function in essential hypertension in Taiwanese populations. 14597849 2003
CUI: C0085580
Disease: Essential Hypertension
Essential Hypertension
0.600 GeneticVariation disease BEFREE The TT genotype of a polymorphism encoding threonine instead of methionine (M235T) has been associated not only with increased plasma angiotensinogen concentration but also with essential hypertension. 8593944 1996
CUI: C0085580
Disease: Essential Hypertension
Essential Hypertension
0.600 GeneticVariation disease BEFREE Nine polymorphisms of angiotensinogen gene in the susceptibility to essential hypertension. 11191642 2000
CUI: C0085580
Disease: Essential Hypertension
Essential Hypertension
0.600 GeneticVariation disease BEFREE These data provide evidence in favour of an association between hypertension and a genetic variant of AGT in human EHT, and a marked ethnic difference in the AGT gene. 7852920 1995
CUI: C0085580
Disease: Essential Hypertension
Essential Hypertension
0.600 GeneticVariation disease BEFREE Essential hypertension patients were genotyped for 11 polymorphisms of essential hypertension susceptibility genes including ADD1 (rs4961), GNB3 (rs5443, rs16932941), NOS3 (rs1799983, rs2070744), ACE (rs5186), AGTR1 (rs5186), AGT (rs699, rs4762), MR (rs5534), and TGFB1 (rs1800471). 26335431 2015
CUI: C0085580
Disease: Essential Hypertension
Essential Hypertension
0.600 GeneticVariation disease BEFREE There are now two studies in populations of white European origin and one in African Caribbeans providing support for a role of the angiotensinogen gene locus in human essential hypertension. 8952609 1996
CUI: C0085580
Disease: Essential Hypertension
Essential Hypertension
0.600 GeneticVariation disease BEFREE Angiotensinogen (AGT) is the precursor of one of the most important vasoactive hormone angiotensin II and this gene locus is associated with human essential hypertension. 17475670 2007
CUI: C0085580
Disease: Essential Hypertension
Essential Hypertension
0.600 GeneticVariation disease BEFREE The M235T mutation of the human angiotensinogen gene has been shown to be associated with elevated circulating angiotensinogen concentrations and essential hypertension. 16940224 2006
CUI: C0085580
Disease: Essential Hypertension
Essential Hypertension
0.600 GeneticVariation disease BEFREE In addition to the angiotensin-converting enzyme (ACE) and angiotensinogen (AGT) gene variants, gene-gene interactions may be important causative factors in a complex disease such as young-onset essential hypertension. 12611423 2003